A Multicentre Open-Label Study of the Long-Term Safety of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Non-infectious Intermediate, Posterior, or Pan-uveitis.
Trial Registry Number: No ACTRN